Startups

Producer of gut health binding proteins.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 71

Locations

Company Size

  • 1 - 11

Last Stage Round

Insights

Bactolife, based in Copenhagen, shows strong potential in the biotech and pharmaceutical sectors. By producing gut health binding proteins, Bactolife addresses gut health issues more effectively than probiotics, prebiotics, dietary changes, or medications. This technology can significantly improve patient outcomes by offering a precise method to tackle various gut health problems. With backing from entities like the Bill & Melinda Gates Foundation and Novo A/S, Bactolife is well-positioned for substantial market impact. Their B2B model indicates a focus on forming robust industry partnerships, enhancing growth prospects.

Total Funding
$41.2M

Full Company Profile